Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 27.77B | 28.80B | 28.21B | 32.04B | 32.35B | 25.93B |
Gross Profit | 6.81B | 6.65B | 6.38B | 7.40B | 8.67B | 5.74B |
EBITDA | 509.35M | 1.47B | -1.40M | 2.26B | 4.04B | 574.72M |
Net Income | -759.90M | -84.00M | -1.47B | 365.58M | 2.18B | -1.16B |
Balance Sheet | ||||||
Total Assets | 45.13B | 44.67B | 47.57B | 44.13B | 46.12B | 40.89B |
Cash, Cash Equivalents and Short-Term Investments | 7.79B | 6.76B | 9.90B | 9.36B | 9.81B | 7.29B |
Total Debt | 1.99B | 2.54B | 2.41B | 468.10M | 997.59M | 1.47B |
Total Liabilities | 19.33B | 18.78B | 21.22B | 17.48B | 19.72B | 17.33B |
Stockholders Equity | 23.53B | 23.48B | 23.95B | 24.27B | 23.87B | 21.18B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -2.35B | -789.41M | 970.67M | 1.14B | -1.02B |
Operating Cash Flow | 0.00 | -403.00M | 11.38M | 1.77B | 1.66B | -488.64M |
Investing Cash Flow | 0.00 | -1.48B | 200.18M | -1.46B | 1.76B | 91.80M |
Financing Cash Flow | 0.00 | -787.00M | 1.02B | -1.88B | -1.13B | -1.33B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥5.51B | 7.75 | 4.63% | 24.88% | 8.01% | ||
72 Outperform | ¥9.19B | 21.08 | 4.29% | -25.41% | -45.60% | ||
72 Outperform | ¥8.71B | 8.03 | 2.50% | -51.97% | -56.67% | ||
67 Neutral | ¥12.02B | 6.90 | 2.79% | -6.44% | 28.42% | ||
56 Neutral | HK$13.54B | 4.87 | -5.76% | 5.64% | 8.06% | -42.52% | |
50 Neutral | ¥6.53B | ― | 3.80% | 2.12% | 93.78% | ||
43 Neutral | ¥3.84B | 31.45 | 1.73% | -8.12% | -102.86% |